Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo - Wikidata - thesis-toulmin - TriplyDB

Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo

Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo

http://www.wikidata.org/entity/Q24625463

about

MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1 New molecularly targeted therapies for lung cancer Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling Reciprocal conversion of Gtr1 and Gtr2 nucleotide-binding states by Npr2-Npr3 inactivates TORC1 and induces autophagy.Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A The GATOR2 Component Wdr24 Regulates TORC1 Activity and Lysosome Function Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner The Ras-association domain family (RASSF) members and their role in human tumourigenesis.Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.Spaceflight alters the gene expression profile of cervical cancer cells.Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis microRNAs and lung cancer: tumors and 22-mers.Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer Genomic events associated with progression of pleural malignant mesothelioma.Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.Tumor suppressor gene-based nanotherapy: from test tube to the clinic.Transformation of rodent fibroblasts by the jaagsiekte sheep retrovirus envelope is receptor independent and does not require the surface domain.High-yield production, purification and characterization of functional human duodenal cytochrome b in an Escherichia coli system.Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.SEA you later alli-GATOR--a dynamic regulator of the TORC1 stress response pathway.Tumor suppressor FUS1 signaling pathway.Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.Axial ligation and stoichiometry of heme centers in adrenal cytochrome b561.Ras and rheb signaling in survival and cell death Hyaluronan and hyaluronidase in genitourinary tumors.Hyalurondiase: both a tumor promoter and suppressor.miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.MicroRNAs and lung cancers: from pathogenesis to clinical implications Insight into the relationship between the cell culture model, cell trafficking and siRNA silencing efficiency.Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.Tumor suppressor BLU promotes TRAIL-induced apoptosis by downregulating NF-κB signaling in nasopharyngeal carcinoma.Functional characterization of the nitrogen permease regulator-like-2 candidate tumor suppressor gene in colorectal cancer cell lines.

P2860

Q21194850-D7606639-F140-42E4-A9AA-7E3CC4CBC6E9 Q24294219-9CF72E2D-0FB7-4D4A-AADC-4CBDF245C388 Q24336517-359EF3FE-567E-4D47-BD4C-1881A85F34FA Q24632794-AC3EF365-63AF-4C64-A518-42E827E5071B Q24633809-A53108F6-197E-4741-955A-7FBD2E39259A Q24680988-4FD8A472-7329-462A-B2FB-72DCC4ED52A7 Q26741367-CC59C44F-F650-4C7A-9434-E37E429352B3 Q27933364-9859F950-1B50-4CDF-A9A2-59A249F4973C Q27938705-1460301F-F22A-41E6-AF89-E61E1FCCB4CE Q28115362-F918D9D1-2911-4658-9145-6718F47A9847 Q28482937-215D1B5F-A0BB-4620-9A2F-7ACE89F387F8 Q28534476-9AC66A17-6B89-47EF-A128-AA2BCC68FBCE Q31121564-4369FBE8-E5BC-425D-BB29-52B35299F684 Q33535501-1342759D-AF8B-4D36-A0C4-943AC346A041 Q33579402-62BA6230-A0E8-4A3C-A4D8-9CF9AAD39C98 Q33631419-2F295190-D286-4F61-8F53-A953FC8BC77B Q33654122-A9A5B618-BF63-45B4-A2FE-A90F2785168A Q33721470-59B6C893-F778-4C3E-B9B7-9160A0502180 Q33910328-768937EF-D02E-4862-8860-698C2CA9B59B Q33919055-63D41E59-96B5-442C-8982-B4AB95299C20 Q34103109-C9B59958-0D87-4C49-9AE2-A8492161F98B Q34315482-FC883767-52CD-42AC-9049-824ED45BF7BF Q34730883-9CF8F038-C635-4AC6-9F03-43E437DD454E Q34997208-5FE15695-C6D3-4B03-8AF4-D07B60EEACD0 Q35098004-B850AF31-699E-4425-8D2B-FC011FE03D58 Q35656213-A417A650-DC35-4E20-A1A1-541C8D9B5971 Q35803423-D170A8C0-DAAE-4A46-9D36-9802FF29CDC6 Q36018413-21281235-7F9B-4627-99EF-AB36BA9A7E44 Q36517724-A4D15896-B917-4384-AB22-10CBE9AB604D Q36906578-ED35FAE1-D414-4002-8FFF-C6F0904A3C28 Q37061781-7F814A34-92BD-4C9F-A081-84D430A4FB60 Q37072219-BB636639-C3A1-459D-9B6D-4E1F0A25C5F9 Q37151526-3C434E6C-9BEE-451F-80CA-C198C113FECD Q37340463-C2EE1A37-035F-42C3-8308-C7EE0554593A Q37688577-FE073967-0448-45E3-ADF6-0DF12B255AF0 Q38005062-41EB7888-E1AB-4F0E-B389-0630B2E6F2F1 Q38761503-D257404F-BBE4-40E4-A8C5-A7EE4DBCC989 Q39784143-674C12E6-B563-4CE2-ACF9-3BA3D90F38FF Q40393121-2A5A32FA-F1EA-46B9-929D-C383D3D0F7C9 Q42208495-CC41E5E2-35F0-4EE7-9EEE-E958C16366C3

P2860

Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo

http://www.wikidata.org/entity/Q24625463

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Expression of several genes in ...... ctivities in vitro and in vivo

@ast

Expression of several genes in ...... ctivities in vitro and in vivo

@en

Expression of several genes in ...... ctivities in vitro and in vivo

@nl

type

label

Expression of several genes in ...... ctivities in vitro and in vivo

@ast

Expression of several genes in ...... ctivities in vitro and in vivo

@en

Expression of several genes in ...... ctivities in vitro and in vivo

@nl

prefLabel

Expression of several genes in ...... ctivities in vitro and in vivo

@ast

Expression of several genes in ...... ctivities in vitro and in vivo

@en

Expression of several genes in ...... ctivities in vitro and in vivo

@nl

P1433

Q24625463-8643D004-BD31-426D-AA81-706C7D1AF53B

P1476

Q24625463-534F1B4E-CB23-4B20-8DE1-4CC59CD1B86E

P2093

Q24625463-02A11BE5-4F14-4E26-A143-00E8C46D754D

Q24625463-0CFC22BB-0F0D-4CBD-A1D8-A90693EF225A

Q24625463-234592B9-B7A6-4425-AEA9-AA35298AFBEA

Q24625463-248A8014-4849-4F84-BABD-88554429832C

Q24625463-4E19BD3D-1131-486C-9B48-858DD26FE967

Q24625463-508C055F-770B-4E20-9780-5FC98617802D

Q24625463-6B188D1B-7BCF-4B5D-834D-4ADB83BCF00B

Q24625463-7CA990F6-04B5-42F9-B9C4-A38FBCB952E8

Q24625463-8477CCD9-F13C-4362-A0DD-A012E09A7308

Q24625463-91349EFA-D397-4FA2-BA7F-B4C759B977B8

P2860

Q24625463-0BB1FF25-1337-48AE-9356-11CF79C01056

Q24625463-158060FD-D532-4857-8788-7994A2D27B05

Q24625463-1DD96D91-C0BC-4F74-ADFD-87A19DB12F5F

Q24625463-2A4181E8-F690-4780-8972-1F0E3D0BCB38

Q24625463-342D34B5-308B-4D35-A149-E2F75751DE23

Q24625463-39EEC037-F7C2-48D2-A9A8-72CCAA0F7FCE

Q24625463-49842205-D7E1-4015-8771-F30BA86C9069

Q24625463-6299C824-2C8E-4641-98FF-28F0D3C4F29F

Q24625463-6A76EF47-5266-41CE-84C2-513E2367202C

Q24625463-8551F6FA-12E3-4FF0-A8C9-5C3A31AF760A

P304

Q24625463-6EEE8381-F18C-4176-B793-BB4DFF1AFD4B

P31

Q24625463-1B3B69F0-6D76-494A-A55B-AD7EB415DB60

P3181

Q24625463-57E5617D-1D2F-4BD7-99E9-633296E1DCCA

P407

Q24625463-B8B62FD0-DBCE-48E8-8F6E-FDB398702803

P433

Q24625463-FB835249-7B35-4170-9D9D-9EFBD35C31DA

P478

Q24625463-2ECC7E92-8D5D-48E6-9994-4726C403AD39

P577

Q24625463-00D24782-0F33-43E2-B266-5C1BFDAC38EE

P698

Q24625463-7063D2F0-C125-4CD4-B08E-9643F07B351E

P921

Q24625463-A3327598-7346-49D0-BF81-57B3702F4CCF

Q24625463-DBBD3587-D59C-47D2-8336-6B92472C9655

P932

Q24625463-7C723DB9-3EE6-4D81-89EE-6C94E69BD32F

P3181

P1433

Cancer Research

P1476

Expression of several genes in ...... ctivities in vitro and in vivo

@en

P2093

Bingliang Fang

http://www.w3.org/2001/XMLSchema#string

Boning Gao

http://www.w3.org/2001/XMLSchema#string

Craig Kamibayashi

http://www.w3.org/2001/XMLSchema#string

David Burbee

http://www.w3.org/2001/XMLSchema#string

E Neely Atkinson

http://www.w3.org/2001/XMLSchema#string

Jack A Roth

http://www.w3.org/2001/XMLSchema#string

John D Minna

http://www.w3.org/2001/XMLSchema#string

Kai Xu

http://www.w3.org/2001/XMLSchema#string

Lin Ji

http://www.w3.org/2001/XMLSchema#string

Masahiko Nishizaki

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

p53, the cellular gatekeeper for growth and division

The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium

High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent.

The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer.

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.

p53: death star.

P304

2715-2720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1728016

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11980673

http://www.w3.org/2001/XMLSchema#string

P921

P932

3478680

http://www.w3.org/2001/XMLSchema#string